EligibleTrials

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

Recruiting · NCT05136703 · Interventional (participants receive a specific treatment) · Lead sponsor: Florida International University

View the official record on ClinicalTrials.gov →
HIVDepression

Interventions studied

Antiretroviral Therapy (ART) Adherence CounselingCognitive-Behavioral Therapy for Adherence and Depression (CBT-AD)

What this trial is about

The purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in people living with HIV.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.